Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Academic Drug Discovery

Susanne Muller Knapp's Biography

Susanne Muller Knapp, Group Head Structural Genomics Consortium (SGC), University Of Oxford

Susanne Müller-Knapp studied Human Biology in Marburg Germany followed by a PhD in molecular biology at the Karolinska Institute in Stockholm, Sweden (1997). She then had more than 6 years of postdoctoral training in the area of inflammation and gene regulation at the Karolinska Institute and at the DIBIT San Raffaele Scientific Institute in Milan, Italy.
In 2004 Susanne joined the Structural Genomics Consortium, SGC, in Oxford. The SGC is an international public private partnership that comprises 9 international pharmaceutical companies and a large network of academic and industrial collaborators. Susanne worked at the SGC first as External Research Manager and then Scientific Coordinator. Currently, she is the Project Manager of the Epigenetic Probe Project, which generates tool compounds with defined specificity and selectivity for epigenetic targets. She also heads the cell based assay group at the SGC testing the cellular activity of the in vitro characterised tool compounds. The focus is on first demonstrating the on-target effect of the characterised compounds in cells to provide a well validated compound. These inhibitors are then used to explore biology and disease relevance of the targets and dissect findings obtained by genetic methods.

Susanne Muller Knapp Image

The Impact Of Chemical Probes On Academic Drug Discovery

Tuesday, 7 March 2017 at 09:00

Add to Calendar ▼2017-03-07 09:00:002017-03-07 10:00:00Europe/LondonThe Impact Of Chemical Probes On Academic Drug

Chemical probes, well-characterized, potent, selective and cell-active tool compounds, are essential tools in biology and target validation. Several chemical probe programs of the SGC will be presented.

Add to Calendar ▼2017-03-06 00:00:002017-03-07 00:00:00Europe/LondonAcademic Drug